TY - JOUR
T1 - Haploinsufficiency in tumor predisposition syndromes
T2 - Altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation
AU - Peri, Suraj
AU - Caretti, Elena
AU - Tricarico, Rossella
AU - Devarajan, Karthik
AU - Cheung, Mitchell
AU - Sementino, Eleonora
AU - Menges, Craig W.
AU - Nicolas, Emmanuelle
AU - Vanderveer, Lisa A.
AU - Howard, Sharon
AU - Conrad, Peggy
AU - Crowell, James A.
AU - Campbell, Kerry S.
AU - Ross, Eric A.
AU - Godwin, Andrew K.
AU - Yeung, Anthony T.
AU - Clapper, Margie L.
AU - Uzzo, Robert G.
AU - Henske, Elizabeth P.
AU - Ricketts, Christopher J.
AU - Vocke, Cathy D.
AU - Marston Linehan, W.
AU - Testa, Joseph R.
AU - Bellacosa, Alfonso
AU - Kopelovich, Levy
AU - Knudson, Alfred G.
PY - 2017
Y1 - 2017
N2 - Tumor suppressor genes and their effector pathways have been identified for many dominantly heritable cancers, enabling efforts to intervene early in the course of disease. Our approach on the subject of early intervention was to investigate gene expression patterns of morphologically normal "one-hit" cells before they become hemizygous or homozygous for the inherited mutant gene which is usually required for tumor formation. Here, we studied histologically non-transformed renal epithelial cells from patients with inherited disorders that predispose to renal tumors, including von Hippel-Lindau (VHL) disease and Tuberous Sclerosis (TSC). As controls, we studied histologically normal cells from non-cancerous renal epithelium of patients with sporadic clear cell renal cell carcinoma (ccRCC). Gene expression analyses of VHLmut/wt or TSC1/2mut/wt versus wild-type (WT) cells revealed transcriptomic alterations previously implicated in the transition to precancerous renal lesions. For example, the gene expression changes in VHLmut/wt cells were consistent with activation of the hypoxia response, associated, in part, with the "Warburg effect". Knockdown of any remaining VHL mRNA using shRNA induced secondary expression changes, such as activation of NFκB and interferon pathways, that are fundamentally important in the development of RCC. We posit that this is a general pattern of hereditary cancer predisposition, wherein haploinsufficiency for VHL or TSC1/2, or potentially othertumor susceptibility genes, is sufficient to promote development of early lesions, while cancer results from inactivation of the remaining normal allele. The gene expression changes identified here are related to the metabolic basis of renal cancer and may constitute suitable targets for early intervention.
AB - Tumor suppressor genes and their effector pathways have been identified for many dominantly heritable cancers, enabling efforts to intervene early in the course of disease. Our approach on the subject of early intervention was to investigate gene expression patterns of morphologically normal "one-hit" cells before they become hemizygous or homozygous for the inherited mutant gene which is usually required for tumor formation. Here, we studied histologically non-transformed renal epithelial cells from patients with inherited disorders that predispose to renal tumors, including von Hippel-Lindau (VHL) disease and Tuberous Sclerosis (TSC). As controls, we studied histologically normal cells from non-cancerous renal epithelium of patients with sporadic clear cell renal cell carcinoma (ccRCC). Gene expression analyses of VHLmut/wt or TSC1/2mut/wt versus wild-type (WT) cells revealed transcriptomic alterations previously implicated in the transition to precancerous renal lesions. For example, the gene expression changes in VHLmut/wt cells were consistent with activation of the hypoxia response, associated, in part, with the "Warburg effect". Knockdown of any remaining VHL mRNA using shRNA induced secondary expression changes, such as activation of NFκB and interferon pathways, that are fundamentally important in the development of RCC. We posit that this is a general pattern of hereditary cancer predisposition, wherein haploinsufficiency for VHL or TSC1/2, or potentially othertumor susceptibility genes, is sufficient to promote development of early lesions, while cancer results from inactivation of the remaining normal allele. The gene expression changes identified here are related to the metabolic basis of renal cancer and may constitute suitable targets for early intervention.
KW - Calcium-Binding Proteins/genetics
KW - Carcinoma, Renal Cell/genetics
KW - Cell Line, Tumor
KW - Gene Expression Profiling
KW - Gene Knockdown Techniques
KW - Genetic Predisposition to Disease/genetics
KW - Haploinsufficiency
KW - Heterozygote
KW - Humans
KW - Immunoblotting
KW - Kidney Neoplasms/genetics
KW - Mutation
KW - Oligonucleotide Array Sequence Analysis
KW - Real-Time Polymerase Chain Reaction
KW - Transcriptome
KW - Von Hippel-Lindau Tumor Suppressor Protein/genetics
UR - http://www.scopus.com/inward/record.url?scp=85015176644&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.12192
DO - 10.18632/oncotarget.12192
M3 - Article
C2 - 27682873
AN - SCOPUS:85015176644
SN - 1949-2553
VL - 8
SP - 17628
EP - 17642
JO - Oncotarget
JF - Oncotarget
IS - 11
ER -